Burlington, MA -- September 27, 2024 – Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced that it has received the Endpoints 11 Award from Endpoints News, an...